Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention

Clinical trial NCT07581808 · RECRUITING

Trial details

NCT number: NCT07581808
Sponsor: University Medical Centre Ljubljana
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Hypercholesterolemia Atherosclerotic Cardiovascular Disease (ASCVD)

Start date: 2026-05-18
Primary completion: 2027-05-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.